PSNL (Personalis) Short Interest


PSNL Personalis Inc PSNL
59 GF Score
Price $11.36
GF Value $2.07
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Personalis Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

PSNL vs CDNA, OPK, NEO: Short Interest Comparison

For the Diagnostics & Research subindustry, Personalis's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Personalis Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Personalis's Short Interest distribution charts can be found below:

* The bar in red indicates where Personalis's Short Interest falls into.


PSNL
59GF Score
Personalis Inc PSNL
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Personalis (PSNL) Overvalued in 2026?

Based on GuruFocus' analysis, Personalis stock appears to be overvalued. The current stock price of $11.36 is trading 448.8% above its estimated GF Value™ of $2.07. GuruFocus considers Personalis to be Significantly Overvalued.

Key valuation signals for PSNL:

  • Short Interest:
  • GF Value™: $2.07 vs. price of $11.36 (448.8% above fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the PSNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Personalis Business Description

Other Exchanges 04X:Germany
Address 6600 Dumbarton Circle, Fremont, CA, USA, 94555
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
59GF Score

Get the complete analysis for PSNL

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.36
Price
$2.07
GF Value